Raymond James & Associates lowered its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report) by 2.4% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 352,240 shares of the real estate investment trust’s stock after selling 8,683 shares during the period. Raymond James & Associates’ holdings in Omega Healthcare Investors were worth $14,336,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Park Avenue Securities LLC increased its holdings in shares of Omega Healthcare Investors by 5.7% during the first quarter. Park Avenue Securities LLC now owns 10,066 shares of the real estate investment trust’s stock valued at $319,000 after acquiring an additional 544 shares in the last quarter. Hennion & Walsh Asset Management Inc. boosted its position in shares of Omega Healthcare Investors by 96.7% during the first quarter. Hennion & Walsh Asset Management Inc. now owns 21,799 shares of the real estate investment trust’s stock worth $690,000 after buying an additional 10,714 shares during the period. Cornerstone Wealth Group LLC acquired a new position in shares of Omega Healthcare Investors in the first quarter valued at approximately $231,000. Allspring Global Investments Holdings LLC boosted its holdings in Omega Healthcare Investors by 93.7% in the first quarter. Allspring Global Investments Holdings LLC now owns 4,803 shares of the real estate investment trust’s stock valued at $152,000 after purchasing an additional 2,324 shares during the period. Finally, State of Michigan Retirement System raised its holdings in Omega Healthcare Investors by 2.6% in the first quarter. State of Michigan Retirement System now owns 60,263 shares of the real estate investment trust’s stock valued at $1,909,000 after acquiring an additional 1,500 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Omega Healthcare Investors
In other news, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
Read Our Latest Analysis on Omega Healthcare Investors
Omega Healthcare Investors Stock Down 0.4 %
Shares of NYSE:OHI opened at $41.55 on Monday. Omega Healthcare Investors, Inc. has a 1-year low of $27.53 and a 1-year high of $41.93. The company has a debt-to-equity ratio of 1.19, a current ratio of 5.79 and a quick ratio of 5.79. The stock has a market cap of $10.27 billion, a P/E ratio of 37.43, a P/E/G ratio of 1.33 and a beta of 1.00. The firm has a fifty day moving average price of $40.10 and a 200 day moving average price of $35.60.
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last announced its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The business had revenue of $252.70 million during the quarter, compared to analysts’ expectations of $205.92 million. During the same period in the previous year, the company posted $0.74 earnings per share. Omega Healthcare Investors’s quarterly revenue was up 17.5% on a year-over-year basis. Sell-side analysts predict that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current year.
About Omega Healthcare Investors
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Further Reading
- Five stocks we like better than Omega Healthcare Investors
- Do ETFs Pay Dividends? What You Need to Know
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- The How And Why of Investing in Oil Stocks
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- ETF Screener: Uses and Step-by-Step Guide
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report).
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.